We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 01, 2020

Real-World Use of Cardioprotective Glucose-Lowering Drugs in Patients With T2D and CVD

Diabetes, Obesity & Metabolism

 

Additional Info

Diabetes, Obesity & Metabolism
Real-World Use of Cardioprotective Glucose-Lowering Drugs in Patients With Type 2 Diabetes and Cardiovascular Disease: A Danish Nationwide Cohort Study, 2012 to 2019
Diabetes Obes Metab 2020 Nov 02;[EPub Ahead of Print], KL Funck, JS Knudsen, TK Hansen, RW Thomsen, EL Grove

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading